Saturday, 12 September 2020

Gilead Nears Deal To Buy Immunomedics For More Than $20 Billion, WSJ Reports

Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter.

from Top Business News- News18.com https://ift.tt/3bU5irC
Previous Post
Next Post

post written by:

0 comments: